RetCAD: Precision Eye Health Analysis with AI
Introducing RetCAD, ushering a brighter and clearer future. Leveraging advanced AI, it swiftly identifies eye concerns such as Age-related Macular Degeneration (AMD) and Diabetic Retinopathy (DR). RetCAD meticulously analyses fundus images, promptly flagging potential risks within a minute. This ensures patients receive timely care, facilitating swift intervention, prioritising patient well-being, and optimising the workflow for eye-care professionals. As a CE-certified tool, RetCAD’s outstanding performance aligns with that of human experts, reducing the workload on specialists and enhancing the standard of patient care. RetCAD guarantees accuracy while ensuring patient confidentiality and upholding data integrity through secure and efficient data transfer processes.